Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
PUT
Pan American Silver
PAAS
$20.2B
| $293K | ﹤0.01% |
17,800
+6,000
| +51% | +$85.8K |
|
|
ECHO
3577
EchoStar
ECHO
$25.3B
| $292K | ﹤0.01% |
9,077
+8,714
| +2,401% | +$285K |
|
|
GGP
3578
CALL
DELISTED
GGP Inc.
GGP
| $292K | ﹤0.01% |
9,800
-2,100
| -18% | -$59.3K |
|
|
TRVN
3579
DELISTED
Trevena, Inc.
TRVN
| $290K | ﹤0.01% |
74
+54
| +270% | +$254K |
|
3580
PUT
Equinor
EQNR
$93.7B
| $289K | ﹤0.01% |
16,700
+9,500
| +132% | +$155K |
|
3581
PUT
Old Dominion Freight Line
ODFL
$44B
| $289K | ﹤0.01% |
14,400
+8,400
| +140% | +$180K |
|
3582
PUT
Kinross Gold
KGC
$30.4B
| $288K | ﹤0.01% |
58,900
-291,100
| -83% | -$1.39M |
|
3583
AtriCure
ATRC
$2.01B
| $287K | ﹤0.01% |
20,314
+6,918
| +52% | +$105K |
|
|
EXAS
3584
PUT
DELISTED
Exact Sciences
EXAS
| $287K | ﹤0.01% |
23,400
+5,600
| +31% | +$42.2K |
|
3585
iShares Gold Trust
IAU
$66B
| $287K | ﹤0.01% |
11,273
-1,453
| -11% | -$35.3K |
|
|
CRR
3586
PUT
DELISTED
Carbo Ceramics Inc.
CRR
| $287K | ﹤0.01% |
21,900
+500
| +2% | +$6.73K |
|
|
SONC
3587
PUT
DELISTED
Sonic Corp
SONC
| $287K | ﹤0.01% |
10,600
+300
| +3% | +$9.59K |
|
3588
CALL
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $286K | ﹤0.01% |
14,600
+4,700
| +47% | +$92K |
|
3589
PUT
Lear
LEA
$7.93B
| $285K | ﹤0.01% |
2,800
-400
| -13% | -$45K |
|
|
CRR
3590
DELISTED
Carbo Ceramics Inc.
CRR
| $285K | ﹤0.01% |
21,734
+5,587
| +35% | +$75.2K |
|
3591
MGIC Investment
MTG
$6.21B
| $284K | ﹤0.01% |
47,662
-501,456
| -91% | -$3.42M |
|
|
BRFS
3592
DELISTED
BRF SA
BRFS
| $283K | ﹤0.01% |
20,298
-11,574
| -36% | -$156K |
|
3593
PUT
Digital Realty Trust
DLR
$71.3B
| $283K | ﹤0.01% |
2,600
+1,400
| +117% | +$133K |
|
3594
CALL
Thomson Reuters
TRI
$43.7B
| $283K | ﹤0.01% |
6,032
+1,034
| +21% | +$49.3K |
|
|
CSII
3595
DELISTED
Cardiovascular Systems, Inc.
CSII
| $283K | ﹤0.01% |
15,376
+10,939
| +247% | +$171K |
|
3596
CALL
ProShares UltraShort Russell2000
TWM
$42.2M
| $282K | ﹤0.01% |
405
-630
| -61% | -$465K |
|
|
IMGN
3597
CALL
DELISTED
Immunogen Inc
IMGN
| $282K | ﹤0.01% |
+91,600
| New | +$574K |
|
|
IMGN
3598
PUT
DELISTED
Immunogen Inc
IMGN
| $282K | ﹤0.01% |
+91,600
| New | +$574K |
|
3599
Ameris Bancorp
ABCB
$5.92B
| $281K | ﹤0.01% |
9,479
-728
| -7% | -$22.2K |
|
3600
PUT
Cardinal Health
CAH
$55.7B
| $281K | ﹤0.01% |
3,600
+1,000
| +38% | +$79.7K |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.